702 A RANDOMISED, TWO‐PERIOD CROSS‐OVER STUDY TO INVESTIGATE THE EFFICACY OF THE TRPV1 ANTAGONIST SB‐705498 IN ACUTE MIGRAINE
2009; Wiley; Volume: 13; Issue: S1 Linguagem: Inglês
10.1016/s1090-3801(09)60705-9
ISSN1532-2149
AutoresB.A. Chizh, James A. Palmer, Robert Lai, F. Guillard, Jonathan Bullman, Amanda Baines, Antonio Napolitano, Jonathan Appleby,
Tópico(s)Fibromyalgia and Chronic Fatigue Syndrome Research
ResumoEuropean Journal of PainVolume 13, Issue S1 p. S202a-S202 702 A RANDOMISED, TWO-PERIOD CROSS-OVER STUDY TO INVESTIGATE THE EFFICACY OF THE TRPV1 ANTAGONIST SB-705498 IN ACUTE MIGRAINE B. Chizh, GlaxoSmithKline Addenbrooke's Centre for Clinical Investigation, Cambridge, United KingdomSearch for more papers by this authorJ. Palmer, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorR. Lai, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorF. Guillard, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorJ. Bullman, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorA. Baines, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorA. Napolitano, GlaxoSmithKline Addenbrooke's Centre for Clinical Investigation, Cambridge, United KingdomSearch for more papers by this authorJ. Appleby, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this author B. Chizh, GlaxoSmithKline Addenbrooke's Centre for Clinical Investigation, Cambridge, United KingdomSearch for more papers by this authorJ. Palmer, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorR. Lai, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorF. Guillard, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorJ. Bullman, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorA. Baines, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this authorA. Napolitano, GlaxoSmithKline Addenbrooke's Centre for Clinical Investigation, Cambridge, United KingdomSearch for more papers by this authorJ. Appleby, GlaxoSmithKline Research & Development, Harlow, United KingdomSearch for more papers by this author First published: 12 January 2012 https://doi.org/10.1016/S1090-3801(09)60705-9Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume13, IssueS1September 2009Pages S202a-S202 RelatedInformation
Referência(s)